From AIDSmap, Michael Carter reports on a study designed to examine the association between chronic depression and clinical outcomes.
Increased time spent living with depression is associated with poorer engagement with the HIV care continuum, investigators from the United States report in JAMA Psychiatry. Chronic depression was associated with missing appointments, a detectable viral load and an increased mortality risk.
“We found that a greater proportion of time spent with depression increased the risk of missed primary care appointments and lack of viral suppression in a dose-response manner,” comment the autho
Oren Adamson received a prescription for pre-exposure prophylaxis treatment in July of last year. Also known as PrEP, the once daily pill is believed to reduce the risk of contracting HIV by more than 90 per cent. Health Canada approved PrEP in the form of the drug Truvada last year, but it has remained too expensive for many patients at $1,000 month. It's considerably cheaper – $70 – in the United States, prompting Mr. Adamson to drive from his home in Vancouver across the bo
From The Conversation, Henry Zakumumpa reports on how Uganda is closing its funding gap for the scale-up of antiretroviral treatment and service delivery
Over the last 15 years, there’s been a rapid increase in the number of patients receiving HIV treatment in sub-Saharan Africa. This has largely depended on foreign aid, particularly from global aid organisations such as the President’s Emergency Plan for AIDS Relief (PEPFAR) and The Global Fund.
Millions of lives have been saved and the quality of life of those living with HIV has been improved dramatically.
In recent years there have been persistent reports of a decline in the amou
From AIDSmap, Gus Cairns reports on the PrEP In Europe Summit 2018
The biggest barrier to HIV pre-exposure prophylaxis (PrEP) becoming more available and more widely used is not cost so much as widespread acceptance of the status quo in HIV prevention, the first-ever European PrEP Summit, held in Amsterdam ten days ago, heard.
Ignorance – among politicians, among healthcare workers, and among potential users of PrEP – was the main reason Europe lags far behind the USA in PrEP provision, despite there being a possibly more favourable climate in terms of p
From Posterity Media, Morenike Oluwatoyin Folayan and Morolake Odetoyinbo report on two inspiring case studies in HIV activism.
A Treatment Action Campaign protest
At the just-concluded 2018 Partners Forum that held from February 13 -15, 2018 at the Crowne Plaza, Johannesburg, South Africa, participants were taken through an Advocacy 001 class. The lecture sounded very much like what advocacy should be – planned, with timelines and targets, adequately funded with measureable targets. Sadly, the history of HIV and AIDS activism in Africa was not such structured campaigns.
HIV and AIDS activism evolved out of a d
"The sole issue in this case is whether psychological harm said to have been caused by non-disclosure of HIV status vitiates consent to sexual activity. The short answer is no, it does not." The Globe and Mail reports.
Wesley Vandinter/Getty Images
To read the complete article, visit the Globe and Mail, here.
HALIFAX (CP) -- Nova Scotia's highest court has overturned the sexual-assault convictions of an HIV-positive former boxer who slept with two women, saying their consent wasn't diminished by the man not disclosing his condition.
Claude Thompson was found guilty of sexual-assault causing bodily harm of two women in Antigonish, N.S., and sentenced to 30 months in jail. In a written ruling released Th
Championing Healthy Public Policy for Older Adults Living with HIV in Canada.
Please consider joining Realize for one of three upcoming online consultations on Championing Healthy Public Policy for Older Adults Living with HIV in Canada.
These online consultations are open to people living with HIV, service providers, health professionals, researchers, policy makers and others with a shared interest in these issues.
Please consider joining Realize for one of three upcoming online consultations on Championing Healthy Public Policy for Older Adults Living with
From Uganda, Matovu William's first article as a regular contributor to PositiveLite.com discusses the many benefits of antiretroviral theraoy (ART).
According to UNAIDS, there were approximately 36.7 million people worldwide living with HIV/AIDS at the end of 2016. Of these, 2.1 million were children (<15 years old). As of July 2017, 20.9 million people living with HIV were accessing antiretroviral therapy (ART) globally, up from 15.8 million in June 2015, 7.5 million in 2010, and less than one million in 2000.
HIV treatment known as Antiretroviral Therapy (ART) is medication which is given to HIV positive people to treat HIV but it do
“Mom, I’m HIV-positive.”
When I hear those words,
I want to grab all the best experts and latest practices,
to advocate for human rights and access to care,
and to reject HIV criminalization.
But most of all, I want to hold you close in a big hug.
I want you to know
that you are loved
no less than you have always been
Your strengths can’t be taken from you--
You flash with energy even while standing still.
You excel in languages,
and in your studies.
What are yo
Add your voice and endorse our call to Eliminate hepatitis C in Canada at ctac.ca/EliminateHepC
Did you know that an estimated 220,000 – 245,000 Canadians are infected with hepatitis C and that around 44% of those individuals are unaware of their status?
Hepatitis C is curable, and although Canada has signed up to the World Health Organisation’s target to eliminate viral hepatitis as a public health threat by 2030, we aren't on course to achieve it.
That's why CTAC needs your help!
“We found that about 1 in 8 patients has undiagnosed and untreated hypertension,” write the researchers. From AIDSmap, Michael Carter reports.
There is a high prevalence of hypertension among HIV-positive patients in the United States and many of these individuals are not receiving hypertensive therapy, investigators report in Clinical Infectious Diseases. Overall, 42% of patients were classified as hypertensive and 13% of these patients were undiagnosed with a further 26% with uncontrolled high blood pressure despite therapy.
“We found that about 1 in 8 patients has undiagnosed and untreated hypertension,” write the researc
A chemical found in marijuana, known as tetrahydrocannabinol, or THC, has been found to potentially slow the process in which mental decline can occur in up to 50 percent of HIV patients, says a new Michigan State University study.
“It’s believed that cognitive function decreases in many of those with HIV partly due to chronic inflammation that occurs in the brain,” said Norbert Kaminski, lead author of the study, now published in the journal AIDS. “This happens because the immune sys
Scepticism among healthcare providers, patients and pharmacists about the safety and efficacy of generic medications is an important barrier. From AIDSmap, Keith Alcorn reports.
The potential savings from prescribing generic antiretrovirals predicted by economic models may be overstated and numerous barriers need to be overcome to bring down the cost of HIV treatment in higher-income countries, according to the findings of several recently-published analyses.
Switching to cheaper generic versions of some antiretrovirals has been proposed as a means of freeing up money to treat more people with HIV in the United States and other higher-income countries where generics
Study finds strong links between PrEP disruptions and intimate partner violence in Kenya and Uganda. Combined interventions could be key to improving adherence and linking victims to support services. From Avert.org, Francesca Harrington-Edmans reports.
Photo credit: istock/znm
People who experience intimate partner violence (IPV) are more likely to miss doses of pre-exposure prophylaxis (PrEP), in Kenya and Uganda, according to new findings published in the Journal of Acquired Immune Deficiency Syndromes (JAIDS).
The study, which recruited participants from four sites across Uganda and Kenya where PrEP was being offered